Assertio Therapeutics
Depomed is a specialty pharmaceutical company that strives to put the patient first in all that they do. Its mission is to improve the lives of patients, families, physicians, providers, and payors by commercializing pain and neurology products and developing drugs for unmet medical needs. Depomed's Neurology and Pain Business currently markets three medicines focused on neuropathic pain and migraine, and it has an emerging Specialty Business focused on orphan drug indications and areas of unmet medical need.
Zyla Life Sciences is a business committed to bringing important products to patients and healthcare providers. Zyla is focused on marketing its portfolio of medicines for pain and inflammation.
Nautilus Neurosciences is a neurology-focused specialty pharmaceutical company committed to providing the healthcare community with relevant products and services that directly benefit those affected by neurological disorders. In the first half of 2010, Nautilus intends to launch a novel product, CAMBIA� (diclofenac potassium for oral solution). Nautilus is backed by Tailwind Capital, a leading private equity firm that invests in health care, business services and media/communications companies.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.